Wednesday, August 24, 2016

BRIEF-Mylan invalidates two of Teva's Copaxone patents

* Mylan invalidates two of Teva's Copaxone 40 mg/ml patents

via U.S. Patent and Trademark Office's Inter Partes Review

proceeding

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)